Holen Sie sich die Stockscreener-App
1,064.74
0.02%
-0.26
Handel nachbörslich:
1070.00
5.26
+0.49%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LLY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Lilly Eli Co Aktie (LLY) Neueste Nachrichten
Lilly Is Looking for Its Next Act Beyond the Weight-Loss Boom - Barron's
Eli Lilly and Company to acquire 3 vaccine development companies for nearly $4 billion - WTHR
Eli Lilly Expands Vaccine Push With Deals Worth Up To $3.8B - Law360
Eli Lilly acquires three vaccine companies for infectious disease portfolio - Managed Healthcare Executive
Investment Firm Closes Out Entire $18.1 Million Position in Biotech Stock, According to Latest SEC Filing - The Motley Fool
Lilly goes on $20 billion buying spree as company seeks next act - The Daily Gazette
What's Going On With Eli Lilly Stock Tuesday?Eli Lilly (NYSE:LLY) - Benzinga
Lilly to buy three vaccine developers for up to $3.8 billion - MSN
Lilly to Buy Three Vaccine Developers for Up to $3.8 Billion - marketscreener.com
Lilly Goes on $20 Billion Buying Spree as Company Seeks Next Act - Yahoo Finance
LLY: Eli Lilly Acquires Three Vaccine Developers for $3.8 Billio - GuruFocus
Eli Lilly targets vaccines market with $3.8B acquisition of three biotech firms - Proactive financial news
Early data for heart drug affirm Lilly’s billion-dollar bet on Verve - BioPharma Dive
Lilly dives into vaccine research with 3 biotech buyouts - BioPharma Dive
Eli Lilly spending $3.8 billion to buy vaccine makers - Axios
Healthcare Takeovers Tick Pass $140 Billion After Latest Lilly Spree - Bloomberg.com
Lilly goes on $21B buying spree to build drug pipeline - dailyjournal.net
Lilly to buy three vaccine developers for nearly US$4 billion in infectious disease push - CTV News
Lilly spending nearly $4B to acquire three vaccine developers - Indianapolis Business Journal
Eli Lilly and Co. splashes out $3.8 billion to acquire three companies, aiming to get a head start in the next round of the global vaccine race - 富途牛牛
Eli Lilly announces acquisition of 3 vaccine makers in $4 billion deal - upi.com
Analyst recommendations: Eli Lilly, AutoZone, BP plc, Ferrari, Samsung Electronics… - marketscreener.com
Positive Clinical Data for Eli Lilly's Gene Editing Therapy VERVE-102 - GuruFocus
Eli Lilly Bets Nearly $4 Billion on Vaccines: Is the Weight-Loss Drug Giant’s Next Growth Curve Here? - TradingKey
Lilly Expands Into Vaccines With Three Infectious Disease Acquisitions Worth Up to $3.8 Billion - citybiz
Lilly to Acquire Vaccine Company in $1.55 Billion Bet on Epstein-Barr Vaccine Development - citybiz
Lilly to Acquire Curevo in Deal Focused on Next-Generation Shingles Vaccine - citybiz
Eli Lilly to buy trio of vaccine developers in $3.8bn outlay - Pharmaceutical Technology
Here’s What the Street is Saying About Eli Lilly and Company (LLY) - Insider Monkey
Eli Lilly (LLY) Acquires Three Vaccine Firms for Nearly $4 Billi - GuruFocus
Eli Lilly's VERVE-102 Shows Promising Results in Early Trial - GuruFocus
Eli Lilly (LLY) Expands Vaccine Portfolio with $4B in Acquisitio - GuruFocus
Eli Lilly (LLY) Expands Infectious Disease R&D Through New Acqui - GuruFocus
Lilly (LLY) to Acquire LimmaTech Biologics for Up to $780 Millio - GuruFocus
Eli Lilly to acquire Curevo, LimmaTech Biologics and Vaccine Company in multibillion dollar bet on infectious - CNBC TV18
LLY Acquires Vaccine Company Focused on Innovative Nanoparticle Technology - GuruFocus
LLY Expands Vaccine Portfolio with Curevo Acquisition - GuruFocus
Lilly to buy three vaccine developers for up to US$3.8 bil - The Edge Malaysia
Eli Lilly Doubles Down On Vaccines Portfolio; Makes Three Key Acquisitions For Nearly $4 Billion - NDTV Profit
Is LLY Overvalued? DCF Says Worth $762 - GuruFocus
Lilly acquiring three vaccine developers for nearly $4-billion - The Globe and Mail
Lilly announces three acquisitions to build infectious disease portfolio | Eli Lilly and Company - investor.lilly.com
Eli Lilly (LLY) Expands Portfolio with Infectious Disease Acquis - GuruFocus
Lilly to acquire three vaccine developers for up to $3.83 billion - Investing.com
BofA raises Eli Lilly stock price target on GLP-1 growth outlook - Investing.com
Lilly to acquire three vaccine developers for nearly $4 billion - Reuters
Lilly to acquire three vaccine developers in deals worth up to $4B - Seeking Alpha
Lilly to acquire three vaccine developers for up to $3.83 billion By Investing.com - Investing.com Canada
Eli Lilly to buy three vaccine firms for $4B - Breakingthenews.net
Eli Lilly to Acquire Curevo, LimmaTech Biologics, Vaccine for Up to $3.83 Billion - Moomoo
Eli Lilly Insiders Added US$4.54m Of Stock To Their Holdings - Moomoo
Exclusive | Lilly Agrees to Buy Trio of Vaccine Developers - WSJ
Leerink reiterates Eli Lilly stock rating on gene therapy progress - Investing.com
$Eli Lilly and Co (LLY.US)$ has been waiting this for2 weeks time after indication comes. target 1100 to sell - Moomoo
Chilton Investment Trims Eli Lilly Stake, Sells 4,088 Shares - The Globe and Mail
Eli Lilly’s one-shot gene therapy shows promise in cutting ‘bad’ cholesterol - Firstpost
Watch Lilly to Buy Three Vaccine Developers for Up to $3.8 Billion - Bloomberg.com
Eli Lilly weight loss drug data supports long-term obesity market position, says UBS - Yahoo Finance UK
Eli Lilly (LLY) Reports Promising Results for Verve-102 in Heart-2 Study - GuruFocus
One-dose gene edit from Eli Lilly kept LDL low for up to 18 months - Stock Titan
Eli Lilly Weight-Loss Drug Retatrutide Posts Impressive Data; Can Novo Nordisk Break Through After Falling Behind Again? - TradingKey
Inside Biotech: Lilly’s retatrutide raises the bar again in the obesity drug race - Proactive financial news
Patients on Lilly's next-gen obesity drug lost 28% of body weight, company says - AOL.com
CNBC Reports Strong Phase 3 Results for Eli Lilly’s Retatrutide - Insider Monkey
1.78%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):